Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,17366,703,0.99 [0.92-1.06],0.7739137845720967
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16807,198,0.99 [0.87-1.13],0.8626564214509097
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19177,118,1.12 [0.95-1.33],0.1863630752709665
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12941,660,1.01 [0.94-1.09],0.7355183928641904
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,19142,83,1.09 [0.89-1.34],0.4002846098949381
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17423,72,0.98 [0.79-1.22],0.8574785482487546
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",20012,82,1.10 [0.90-1.35],0.3415890431570368
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,20025,56,1.05 [0.82-1.35],0.6918537988574567
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,17075,48,1.33 [1.03-1.73],0.029612425934658
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19217,100,0.99 [0.82-1.19],0.8989242602402511
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19183,66,0.87 [0.69-1.09],0.2263282637043181
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,20087,49,1.04 [0.80-1.35],0.7754230687954637
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,20106,63,1.06 [0.84-1.33],0.6414941466172834
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",20098,55,1.11 [0.87-1.42],0.4044260039002316
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,19823,36,1.12 [0.83-1.52],0.4665260025729879
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19058,330,0.95 [0.86-1.06],0.3560473430213486
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18854,126,0.90 [0.77-1.07],0.2324287082100355
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18954,226,0.95 [0.84-1.07],0.3916948538082295
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",15734,65,0.92 [0.73-1.16],0.4793298094232028
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15707,38,0.93 [0.69-1.25],0.6196290406091378
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15886,217,0.98 [0.86-1.11],0.7460491531629923
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15892,223,0.98 [0.87-1.12],0.8092172250538404
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",15865,196,0.94 [0.82-1.07],0.3464090074392333
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",15715,46,0.86 [0.66-1.13],0.2845361257337817
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,17938,441,0.95 [0.87-1.04],0.2806075059716874
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",18835,323,0.98 [0.88-1.09],0.6988172829243076
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19591,111,0.88 [0.74-1.05],0.1620811571422105
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",20143,114,0.99 [0.84-1.18],0.9508398602557608
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,19845,66,0.88 [0.70-1.11],0.2823350466294806
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,20152,55,1.10 [0.86-1.41],0.4603244273254376
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Stomach,20189,38,0.99 [0.73-1.34],0.9399381611661876
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,19908,264,0.91 [0.82-1.02],0.1190848421835025
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,20156,96,0.89 [0.74-1.07],0.2122573502530916
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,20164,62,0.91 [0.72-1.15],0.4102109860997672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",20130,31,0.83 [0.60-1.16],0.2857270823454915
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Haemangioma, any site",20133,31,0.83 [0.60-1.16],0.2858571596297021
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanocytic naevi,20057,101,1.07 [0.89-1.28],0.4726843724347678
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,20176,41,1.02 [0.77-1.35],0.8972285478710187
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,20083,112,0.85 [0.72-1.01],0.0729145910115693
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19224,93,1.05 [0.87-1.27],0.6217977642283019
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,18918,197,0.97 [0.85-1.10],0.6255741629959571
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,18918,197,0.97 [0.85-1.10],0.6255741629959571
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),17042,415,1.00 [0.91-1.10],0.964383061890766
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19757,35,nan [nan-nan],
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19978,51,1.05 [0.81-1.36],0.7184543178469426
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,15836,1162,0.97 [0.91-1.02],0.2527353780759687
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19613,152,1.02 [0.88-1.18],0.8171034508674389
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,17819,111,0.94 [0.79-1.12],0.5013565091884038
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19060,140,0.89 [0.76-1.05],0.1636875958945889
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17808,100,0.93 [0.78-1.12],0.4660897082751171
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,18273,565,0.98 [0.90-1.06],0.6316758854494552
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,18257,549,0.97 [0.89-1.05],0.4716965702471432
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,18711,143,0.83 [0.70-0.98],0.0318309908185248
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",18712,143,0.83 [0.70-0.99],0.0330127723628633
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,15716,1042,0.96 [0.90-1.02],0.1594515056725437
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",14819,145,0.91 [0.78-1.07],0.2497885238300841
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,15634,960,0.96 [0.90-1.02],0.1712087861510068
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,14713,39,0.99 [0.74-1.33],0.952861719302332
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14752,78,0.93 [0.76-1.15],0.5207580880496465
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,17174,580,0.99 [0.92-1.08],0.8605697195215164
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16895,301,0.98 [0.88-1.10],0.7766448349359559
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19718,228,0.99 [0.88-1.13],0.9271912028299898
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19784,175,1.03 [0.90-1.19],0.6527256701068764
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,18401,68,0.88 [0.70-1.10],0.2743520210210081
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",20073,68,0.89 [0.71-1.11],0.3058161550525866
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",16662,68,0.87 [0.70-1.09],0.2382356299655917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Alcohol dependence,18434,101,0.88 [0.73-1.06],0.176239896659888
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,18421,77,1.00 [0.81-1.24],0.9876654537817134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16651,57,0.84 [0.66-1.07],0.155518133320127
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16809,215,1.03 [0.90-1.16],0.6910134704615095
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Depression,19201,184,1.02 [0.89-1.17],0.7597566139048005
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Depression or dysthymia,16589,162,1.03 [0.89-1.19],0.735084817042462
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16680,86,0.98 [0.80-1.20],0.8537399391619255
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Other anxiety disorders,19347,45,1.06 [0.80-1.40],0.6748922568014646
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,17234,1124,0.97 [0.92-1.03],0.2806435722233236
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15524,75,0.94 [0.76-1.16],0.5772613977397644
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,20101,55,0.97 [0.76-1.24],0.8010485672068796
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19070,450,0.94 [0.86-1.03],0.1944610939571703
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Epilepsy,18759,139,0.79 [0.68-0.93],0.0034518928119688
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Migraine,18647,27,0.77 [0.54-1.09],0.1424526522320857
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",20057,20,0.73 [0.48-1.11],0.1416542039463148
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19386,84,nan [nan-nan],
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,18815,195,1.04 [0.91-1.19],0.5307133763775986
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,19578,154,1.02 [0.88-1.19],0.7767601143943333
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19392,409,1.05 [0.96-1.15],0.3164244721261275
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",19091,108,1.05 [0.88-1.25],0.5849712184513258
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,19179,196,1.05 [0.92-1.20],0.4516414501870044
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19916,74,1.00 [0.81-1.24],0.9991672954135822
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,19891,49,0.91 [0.70-1.18],0.4720345213035227
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,19773,100,0.81 [0.68-0.98],0.029753758257958
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19687,265,1.01 [0.90-1.13],0.8430396674832967
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19573,151,0.98 [0.84-1.14],0.8083589930770426
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19491,69,1.02 [0.82-1.27],0.8484318057479967
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19507,85,0.95 [0.77-1.15],0.5828215098917993
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19461,39,1.09 [0.81-1.46],0.5761148593361477
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17684,118,1.03 [0.87-1.22],0.7158425367497461
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17893,327,0.98 [0.89-1.09],0.7376620877015121
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19365,195,1.16 [1.02-1.32],0.0290999532158547
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19846,41,1.34 [1.00-1.79],0.0463351678809839
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2196,41,1.35 [1.00-1.82],0.0525342067416988
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",17691,41,1.33 [0.99-1.77],0.0543591911344389
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19635,80,0.87 [0.71-1.07],0.196895712586316
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19598,43,0.91 [0.68-1.21],0.5042122529637022
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19729,64,1.05 [0.83-1.32],0.6904742755925439
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19768,80,0.91 [0.74-1.11],0.3445855345425693
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,20110,118,0.96 [0.81-1.13],0.6093681521985743
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,19418,87,1.00 [0.82-1.21],0.9690749671561764
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,13592,3106,0.93 [0.89-0.97],0.0007101276212092
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19613,52,0.92 [0.71-1.19],0.5195439219201268
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",14375,2019,0.97 [0.92-1.01],0.1643382422671047
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypertension,14401,2045,0.97 [0.92-1.01],0.1612793681485741
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12416,60,0.99 [0.78-1.26],0.9548883339413456
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",17903,1366,0.89 [0.85-0.94],4.57511650404956e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,17289,752,0.87 [0.81-0.93],0.0001115361707277
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18986,266,0.96 [0.85-1.07],0.4661793595737937
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19311,591,0.92 [0.85-1.00],0.0468706140163021
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",20017,137,0.86 [0.74-1.01],0.0735253716706889
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16948,411,0.91 [0.83-1.00],0.0543388158639453
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,17687,1171,0.90 [0.85-0.96],0.0004791930831006
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19445,101,1.00 [0.83-1.20],0.9896461729268828
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19562,205,1.00 [0.88-1.14],0.9761625146571744
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19423,79,1.02 [0.83-1.26],0.8273776094273444
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19425,81,1.03 [0.84-1.26],0.7851459742474425
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12431,75,1.03 [0.83-1.28],0.7639071525105088
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15879,70,1.06 [0.85-1.32],0.6065784702729171
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,15949,140,0.88 [0.75-1.03],0.1086555026285713
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,10026,113,0.86 [0.72-1.03],0.0947545506080647
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10427,514,0.98 [0.90-1.07],0.6538254107459314
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,15880,71,1.03 [0.83-1.29],0.7566068600415696
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15921,112,0.75 [0.63-0.89],0.0013340099380125
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19101,267,1.04 [0.93-1.17],0.4777272269946897
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19323,145,0.98 [0.84-1.14],0.7576514486482542
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19346,132,0.98 [0.83-1.15],0.8071692441517963
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19417,115,1.03 [0.86-1.22],0.774390430469763
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,19031,68,0.84 [0.67-1.06],0.13661736279859
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19089,126,1.02 [0.86-1.20],0.8548865049806368
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),19071,131,1.06 [0.90-1.24],0.5137240407550767
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,19056,116,1.04 [0.88-1.24],0.6201315571691965
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",20001,110,1.09 [0.92-1.30],0.3273057564766507
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,19232,292,0.96 [0.86-1.07],0.4709129759812855
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypotension,19154,67,1.08 [0.86-1.35],0.5279575123463548
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,15779,1728,1.00 [0.96-1.05],0.9329492898798544
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,20050,75,1.00 [0.81-1.23],0.9938565814421542
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,18445,211,1.03 [0.90-1.17],0.6871414878973556
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",18410,176,1.02 [0.89-1.18],0.7410563797870515
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19385,236,0.97 [0.86-1.10],0.6384311123267947
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19383,234,0.97 [0.85-1.09],0.5672013505568411
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19452,565,1.05 [0.97-1.14],0.1897616307834697
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,18951,64,1.10 [0.87-1.38],0.423088067006892
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,19029,142,1.11 [0.96-1.30],0.1678838709962682
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19248,361,1.03 [0.94-1.14],0.5344743775291515
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,19082,195,1.09 [0.96-1.24],0.2019043438495575
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8827,51,1.00 [0.77-1.29],0.9790407738716196
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18034,734,1.00 [0.93-1.07],0.9530144041012762
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,19079,166,0.88 [0.76-1.02],0.1023470156293249
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19103,190,0.94 [0.81-1.07],0.3387422104807458
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",19103,190,0.94 [0.81-1.07],0.3387422104807458
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",18986,562,1.01 [0.93-1.09],0.8912173872889699
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Asthma,13735,562,1.00 [0.93-1.09],0.9018135757469076
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13444,562,1.00 [0.93-1.08],0.9491797604118294
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13725,552,1.01 [0.93-1.09],0.8301983794652361
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19809,95,0.81 [0.67-0.98],0.0309521774437085
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,19170,75,0.81 [0.66-1.01],0.0634713492399549
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",19879,75,0.81 [0.65-1.01],0.061301453055788
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19164,69,0.76 [0.60-0.95],0.0155759425560721
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,18229,114,0.88 [0.74-1.04],0.1367450267882038
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,18358,243,0.91 [0.81-1.02],0.119824773995239
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19039,110,0.94 [0.79-1.12],0.512193140862415
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,13477,4728,0.97 [0.94-1.01],0.1176132709277612
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19782,313,0.97 [0.87-1.08],0.5710499292573318
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,20170,62,0.88 [0.70-1.12],0.2984962939861092
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,20171,59,0.88 [0.70-1.12],0.3046308948021126
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Dental caries,19567,98,1.20 [1.00-1.44],0.0510109357842623
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19537,68,0.97 [0.77-1.21],0.7765679524464116
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,20162,71,0.91 [0.73-1.13],0.3920984387388596
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19535,66,0.88 [0.71-1.11],0.2869970056696544
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19343,67,0.95 [0.76-1.19],0.6848245268363888
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,20110,50,0.86 [0.67-1.12],0.2583827424381172
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15522,272,0.97 [0.87-1.09],0.6339644333284716
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",16942,1692,0.93 [0.89-0.98],0.0040927593566998
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,15576,326,0.96 [0.86-1.06],0.4030793319624636
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15812,562,0.91 [0.84-0.98],0.0167417397545347
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15319,69,0.88 [0.70-1.10],0.2512622643141898
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15494,244,0.86 [0.76-0.97],0.0151552196304822
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15315,65,0.85 [0.67-1.07],0.1596925403411835
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,15376,126,0.94 [0.80-1.11],0.4877396965951845
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,15405,155,0.98 [0.84-1.13],0.7520749929069777
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",20036,105,1.03 [0.86-1.23],0.737573371989778
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,15354,104,0.82 [0.68-0.98],0.0285278857173304
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15902,652,0.94 [0.87-1.01],0.0832741392140737
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,20057,89,1.06 [0.87-1.28],0.5735857836109161
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,15493,243,1.01 [0.90-1.13],0.8917783518535164
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15392,142,0.80 [0.68-0.93],0.0048995669392434
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,20020,148,0.89 [0.76-1.03],0.1170246513087326
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,20038,70,1.06 [0.85-1.32],0.587641364185663
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Hernia,17263,1731,0.99 [0.94-1.04],0.6694038549292902
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,16495,963,1.00 [0.94-1.06],0.9673053164321924
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,15674,142,0.92 [0.79-1.08],0.3090123901549646
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,15608,76,0.79 [0.64-0.98],0.0290770447714457
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16181,649,1.01 [0.94-1.09],0.8289149095128389
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19462,514,1.05 [0.97-1.14],0.2050835088204501
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,15628,1533,0.95 [0.91-1.00],0.0593241611850983
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19905,49,1.09 [0.84-1.41],0.5305252397968608
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",20128,62,1.12 [0.89-1.40],0.3495421032940661
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Crohn disease,19010,62,1.12 [0.89-1.40],0.3465408425831011
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18998,50,1.14 [0.88-1.47],0.3165371409548029
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",20080,118,0.94 [0.79-1.11],0.46539201112097
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,19066,118,0.94 [0.79-1.11],0.474961425062216
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",19054,106,0.91 [0.76-1.09],0.3119176812058882
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19340,392,1.05 [0.96-1.15],0.3192255911804599
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19338,390,1.05 [0.96-1.15],0.3144216112010402
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14178,83,0.96 [0.78-1.18],0.7108501424428895
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Intestinal stricture,19802,83,0.98 [0.80-1.20],0.8207824974606098
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14154,59,1.08 [0.85-1.38],0.5247294918695041
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,14532,437,0.94 [0.86-1.03],0.1635609539245223
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14171,76,0.94 [0.76-1.16],0.5422192906002502
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14248,153,1.01 [0.87-1.17],0.940059729861838
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Constipation,18903,140,1.02 [0.87-1.19],0.8258311007185722
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19855,42,nan [nan-nan],
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14235,140,0.89 [0.76-1.04],0.1323798755263759
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14183,88,0.94 [0.77-1.14],0.5233863331731139
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,14831,736,0.98 [0.91-1.05],0.5499124980717383
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,14354,259,0.91 [0.81-1.02],0.1070283243505254
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19844,31,nan [nan-nan],
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,19471,122,0.78 [0.66-0.92],0.0036371506465232
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,19419,70,0.74 [0.59-0.93],0.0084734059146868
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19192,301,0.94 [0.84-1.05],0.258473638411221
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,19108,217,0.97 [0.85-1.10],0.6111381576152739
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,18946,55,1.04 [0.81-1.33],0.782356908836336
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18914,23,nan [nan-nan],
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,18950,59,0.87 [0.69-1.11],0.2632159162247277
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),20013,59,0.87 [0.68-1.11],0.2547790163244822
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19018,268,0.94 [0.84-1.05],0.2631060092582965
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18777,27,0.88 [0.62-1.25],0.4808980666230866
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,18771,21,0.85 [0.57-1.27],0.4369122538429747
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18797,47,1.06 [0.81-1.38],0.6952574866513139
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,18948,198,0.91 [0.80-1.04],0.1592862907831321
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,18944,194,0.90 [0.79-1.03],0.1322057582707926
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,17547,1250,0.98 [0.93-1.03],0.4340990191761162
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19814,85,0.94 [0.77-1.15],0.5524155392357939
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19865,386,0.96 [0.87-1.05],0.3472503151606668
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,18868,382,0.99 [0.90-1.09],0.8375984644607901
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19334,393,0.98 [0.90-1.08],0.7504468648731953
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",19026,85,0.97 [0.79-1.18],0.7457845352530794
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19192,251,1.01 [0.90-1.14],0.8099503777396161
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19955,77,0.99 [0.80-1.22],0.9420150617688834
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19941,63,1.05 [0.83-1.32],0.7089571969897404
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19927,49,1.06 [0.82-1.38],0.6630198552637775
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19920,39,0.93 [0.69-1.25],0.6225185238140091
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19919,38,0.94 [0.70-1.27],0.7051190080325287
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19524,45,1.06 [0.81-1.39],0.6826470468312014
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19797,318,0.95 [0.85-1.05],0.3071522857181676
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18559,73,0.89 [0.72-1.11],0.311753346926273
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18523,37,0.75 [0.55-1.02],0.0663439858802528
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18520,34,0.77 [0.56-1.06],0.1148383623168384
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18634,148,1.08 [0.93-1.26],0.3072483295192502
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18621,135,1.03 [0.88-1.21],0.72712913244838
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,14948,3016,1.00 [0.96-1.04],0.9544108211486264
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,16193,1780,1.01 [0.97-1.06],0.5887058050042429
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18285,921,1.04 [0.98-1.11],0.1845860414822393
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14484,71,1.16 [0.93-1.44],0.1956702081786924
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14754,341,0.96 [0.86-1.06],0.3924761690206914
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19955,68,1.15 [0.92-1.44],0.2112137759472225
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19957,59,1.29 [1.02-1.64],0.035785232729622
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,15308,895,1.04 [0.97-1.11],0.2878849457653784
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",17381,895,1.03 [0.97-1.10],0.3320665665530881
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14524,111,1.02 [0.85-1.22],0.8635921530459632
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19396,107,0.99 [0.82-1.18],0.8921930481255911
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,14549,136,0.78 [0.66-0.91],0.0020927037957417
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14456,43,0.93 [0.70-1.24],0.6111806567971446
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14629,216,0.99 [0.87-1.12],0.8647312342985953
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",20082,104,1.06 [0.88-1.27],0.5396733177988485
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,14902,489,1.07 [0.98-1.17],0.1201617423638822
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14656,243,0.98 [0.86-1.10],0.6833647735132165
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15405,992,1.00 [0.94-1.07],0.9316346770066666
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14434,21,0.88 [0.58-1.33],0.5465092212965424
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14454,41,1.09 [0.82-1.46],0.5460635191025184
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14436,23,1.17 [0.80-1.72],0.4188908822574582
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14425,12,1.30 [0.74-2.30],0.3597013576693988
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14919,506,1.06 [0.98-1.15],0.157706726948674
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14854,441,1.06 [0.97-1.16],0.181792620122559
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16339,221,0.96 [0.84-1.08],0.4722213828628034
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19936,36,0.99 [0.73-1.34],0.9338679963201686
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19915,15,0.84 [0.52-1.37],0.4847020151831754
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17688,38,0.91 [0.67-1.23],0.5499538962087378
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17899,249,0.84 [0.75-0.95],0.0041493972534969
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18361,711,0.97 [0.90-1.04],0.3992802823578373
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17792,142,0.85 [0.73-1.00],0.0458504960423553
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17731,81,0.75 [0.61-0.93],0.0074409615855131
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18206,556,1.01 [0.93-1.09],0.8764343223974405
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,17694,44,0.92 [0.70-1.22],0.5770523524795703
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17851,201,1.05 [0.92-1.19],0.48470765445465
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,17736,86,1.05 [0.86-1.28],0.6387080546418358
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17707,57,0.94 [0.73-1.20],0.5995978030674529
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17755,105,0.99 [0.82-1.18],0.8987590332474125
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,17693,43,1.14 [0.86-1.50],0.3607878597432654
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17871,221,1.06 [0.93-1.20],0.3843458902624908
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17560,196,1.09 [0.96-1.25],0.1917753513530514
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17416,52,nan [nan-nan],
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17418,54,1.09 [0.85-1.40],0.5046174168337099
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17415,51,1.10 [0.86-1.42],0.4424061152184049
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17415,51,1.13 [0.88-1.45],0.3435424300575269
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17515,151,1.01 [0.87-1.18],0.869491013252272
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17507,143,0.97 [0.83-1.13],0.7087520408611367
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17572,208,1.01 [0.89-1.14],0.9231206546354386
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17413,49,0.89 [0.68-1.16],0.3882051155726863
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17436,72,1.05 [0.84-1.30],0.6784866085601488
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17456,92,0.96 [0.79-1.17],0.698762295923278
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17402,38,0.86 [0.64-1.16],0.3274771278851255
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17664,300,1.03 [0.93-1.15],0.5523613763913053
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17487,123,1.05 [0.89-1.25],0.5340431747718755
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17527,163,1.07 [0.93-1.24],0.3420160420580408
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19330,89,0.86 [0.70-1.04],0.1248378931641331
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19488,247,0.97 [0.86-1.09],0.6072043496351414
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19287,46,0.94 [0.72-1.23],0.6468717972920812
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19285,44,1.15 [0.87-1.51],0.3362560972070176
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19319,78,1.01 [0.82-1.24],0.9217725660213362
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,15531,1943,0.99 [0.94-1.03],0.5323343691161093
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,17411,1071,0.99 [0.93-1.05],0.6728879902976058
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,17948,214,0.93 [0.82-1.05],0.2565696066266146
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17803,69,0.85 [0.68-1.07],0.167422969328207
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18003,52,0.84 [0.65-1.09],0.1830816775231861
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18005,54,0.97 [0.76-1.25],0.8250067711937281
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,18017,66,0.87 [0.70-1.10],0.243909921341146
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19762,296,1.03 [0.93-1.15],0.5775098564342914
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19773,60,1.14 [0.90-1.45],0.2648349256294359
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19672,206,1.03 [0.90-1.17],0.6812358527812239
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19578,112,1.08 [0.91-1.28],0.3948302811266506
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18354,700,0.96 [0.90-1.03],0.3073425069633841
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,17700,46,0.80 [0.61-1.05],0.1048871793821576
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17714,60,1.00 [0.79-1.27],0.9805672945858174
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17974,320,0.94 [0.85-1.04],0.2508292308825564
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,17768,114,0.93 [0.78-1.10],0.3800026245908402
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,17970,316,0.99 [0.89-1.10],0.8496100713305579
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,16820,480,1.00 [0.92-1.09],0.9930617749671892
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16429,89,0.96 [0.79-1.16],0.6553996471948114
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16428,88,0.96 [0.79-1.17],0.6737163274276496
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16473,133,1.00 [0.85-1.17],0.9702213137538496
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16476,136,1.07 [0.92-1.26],0.3753858607548186
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16515,175,0.94 [0.82-1.09],0.4239461634888014
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19776,62,0.81 [0.64-1.02],0.0770663150731146
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,18423,472,0.99 [0.91-1.08],0.7913382049524047
